Literature DB >> 29436419

Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations.

Mariana Castanheira1.   

Abstract

Recent changes in the occurrence of fungal species and the difficulties in performing reference antifungal susceptibility testing highlight the importance of surveillance of fungal organisms and antifungal resistance rates. K. M. T. Astvad et al. report results from recent (2012 to 2015) fungemia surveillance in Denmark and compare the results to previous data (2004 to 2011), showing a decrease in Candida albicans infections accompanied by an increase in C. glabrata and C. dubliniensis infections (J Clin Microbiol 56:e01564-17, 2018, https://doi.org/10.1128/JCM.01564-17). Azole resistance among C. tropicalis and C. parapsilosis isolates and echinocandin resistance in C. krusei isolates were higher in Denmark than in other regions. Interestingly, the usage of antifungals is higher in Denmark than in other Nordic countries.
Copyright © 2018 American Society for Microbiology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29436419      PMCID: PMC5869818          DOI: 10.1128/JCM.01907-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).

Authors:  Maiken C Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William Hope
Journal:  Clin Microbiol Infect       Date:  2012-05-08       Impact factor: 8.067

Review 2.  Changes in the epidemiological landscape of invasive candidiasis.

Authors:  Frederic Lamoth; Shawn R Lockhart; Elizabeth L Berkow; Thierry Calandra
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

Review 3.  Early diagnosis of invasive mould infections and disease.

Authors:  Frédéric Lamoth; Thierry Calandra
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

Review 4.  Update on blood cultures: how to obtain, process, report, and interpret.

Authors:  T J Kirn; M P Weinstein
Journal:  Clin Microbiol Infect       Date:  2013-03-13       Impact factor: 8.067

5.  Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods.

Authors:  J Meletiadis; E Geertsen; I Curfs-Breuker; J F Meis; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

6.  Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Andrew P Davis; Paul R Rhomberg; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 7.  The current treatment landscape: candidiasis.

Authors:  Matteo Bassetti; Maddalena Peghin; Jean-Francois Timsit
Journal:  J Antimicrob Chemother       Date:  2016-11       Impact factor: 5.790

8.  Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.

Authors:  Maiken Cavling Arendrup; Juan-Luis Rodriguez-Tudela; Steven Park; Guillermo Garcia-Effron; Guillaume Delmas; Manuel Cuenca-Estrella; Alicia Gomez-Lopez; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

9.  Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.

Authors:  K M T Astvad; H K Johansen; B L Røder; F S Rosenvinge; J D Knudsen; L Lemming; H C Schønheyder; R K Hare; L Kristensen; L Nielsen; J B Gertsen; E Dzajic; M Pedersen; C Østergård; B Olesen; T S Søndergaard; M C Arendrup
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

Review 10.  Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis.

Authors:  Stephanie S Buehler; Bereneice Madison; Susan R Snyder; James H Derzon; Nancy E Cornish; Michael A Saubolle; Alice S Weissfeld; Melvin P Weinstein; Edward B Liebow; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

View more
  2 in total

1.  Candida Spp. in Lower Respiratory Tract Secretions - A Ten Years Retrospective Study.

Authors:  Cristina Nicoleta Ciurea; Ario Santini; Anca Delia Mare; Irina Bianca Kosovski; Felicia Toma; Camelia Vintila; Ionela Anca Pintea-Simon; Adrian Man
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-08-05

2.  Invasive Candidiasis Species Distribution and Trends, United States, 2009-2017.

Authors:  Emily E Ricotta; Yi Ling Lai; Ahmed Babiker; Jeffrey R Strich; Sameer S Kadri; Michail S Lionakis; D Rebecca Prevots; Jennifer Adjemian
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.